XT
PASG icon

XTX Topco’s Passage Bio PASG Stock Holding History

XTX Topco’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,627
Closed -$99.1K – 4567
2026
Q1 		$99.1K Buy
+12,627
New +$131K ﹤0.01% 3105
2025
Q3 		– Sell
-3,044
Closed -$24.4K – 3087
2025
Q2 		$24.4K Buy
3,044
+774
+34% +$5.66K ﹤0.01% 2137
2025
Q1 		$16K Buy
+2,270
New +$24.5K ﹤0.01% 2183
2024
Q4 		– Sell
-1,480
Closed -$20.7K – 2768
2024
Q3 		$20.7K Buy
1,480
+628
+74% +$10K ﹤0.01% 1837
2024
Q2 		$13.5K Sell
852
-1,296
-60% -$31.7K ﹤0.01% 1661
2024
Q1 		$58K Buy
2,148
+727
+51% +$17.5K 0.01% 1450
2023
Q4 		$28.7K Buy
1,421
+350
+33% +$4.83K 0.01% 1317
2023
Q3 		$14.1K Buy
+1,071
New +$17.6K ﹤0.01% 1403
2022
Q3 		– Sell
-1,206
Closed -$57K – 1311
2022
Q2 		$57K Sell
1,206
-3,509
-74% -$164K 0.02% 734
2022
Q1 		$292K Buy
+4,715
New +$389K 0.13% 277
2021
Q3 		– Sell
-621
Closed -$164K – 967
2021
Q2 		$164K Buy
+621
New +$192K 0.06% 590

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

XTX Topco's PASG Position: Q2 2026 in Review

XTX Topco sold out of Passage Bio (PASG) in Q2 2026, closing a stake of 12,627 shares — an estimated $99.1K sold.

XTX Topco first reported a position in PASG in Q2 2021 and held it in 11 quarters. The position peaked at $292K in Q1 2022. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • XTX Topco reported no remaining Passage Bio position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 12,627 Passage Bio shares in Q2 2026, an estimated $99.1K.
  • XTX Topco first reported a position in Passage Bio in Q2 2021 and held it in 11 quarters.
  • XTX Topco's Passage Bio position peaked at $292K in Q1 2022.
  • 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.